D. Gomez

发表

Comparative effectiveness of five treatment strategies for early-stage non-small cell lung cancer in the elderly.

Joe Y. Chang, S. Shirvani, Jing Jiang, 2012 .

Clinical Investigation : Thoracic Cancer Comparative Effectiveness of 5 Treatment Strategies for Early-Stage Non-Small Cell Lung Cancer in the Elderly

Joe Y. Chang, S. Shirvani, Jing Jiang, 2012 .

In Vivo Delivery of miR-34a Sensitizes Lung Tumors to Radiation Through RAD51 Regulation

Joe Y. Chang, G. Calin, D. Gomez, 2015, Molecular therapy. Nucleic acids.

Using Pretreatment Radiomics and Delta-Radiomics Features to Predict Non-Small Cell Lung Cancer Patient Outcomes.

R Mohan, L Zhang, P Balter, 2017, International journal of radiation oncology, biology, physics.

Prognostic value of combining a quantitative image feature from positron emission tomography with clinical factors in oligometastatic non-small cell lung cancer.

D. Mackin, D. Fried, L. Court, 2017, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Association between single nucleotide polymorphisms of the transforming growth factor β1 gene and the risk of severe radiation esophagitis in patients with lung cancer.

Daniel Gomez, Zhongxing Liao, Li-E Wang, 2012, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Functional promoter variant rs2868371 of HSPB1 is associated with risk of radiation pneumonitis after chemoradiation for non-small cell lung cancer.

Radhe Mohan, Zhongxing Liao, Ting Xu, 2013, International journal of radiation oncology, biology, physics.

Incorporating single-nucleotide polymorphisms into the Lyman model to improve prediction of radiation pneumonitis.

Radhe Mohan, Daniel Gomez, Zhongxing Liao, 2013, International journal of radiation oncology, biology, physics.

Delta-radiomics features for the prediction of patient outcomes in non–small cell lung cancer

Peter Balter, Radhe Mohan, Daniel Gomez, 2017, Scientific Reports.

Ipilimumab with Stereotactic Ablative Radiation Therapy: Phase I Results and Immunologic Correlates from Peripheral T Cells

Joe Y. Chang, K. Hess, D. Gomez, 2016, Clinical Cancer Research.

Spatial correspondence of 4D CT ventilation and SPECT pulmonary perfusion defects in patients with malignant airway stenosis

Thomas Guerrero, Richard Castillo, Edward Castillo, 2012, Physics in medicine and biology.

Can radiomics features be reproducibly measured from CBCT images for patients with non-small cell lung cancer?

Peter Balter, Daniel Gomez, Laurence Court, 2015, Medical physics.

Adaptive Radiation for Lung Cancer

Joe Y. Chang, D. Gomez, Daniel R. Gomez, 2010, Journal of oncology.

Robust Treatment Comparison Based on Utilities of Semi-Competing Risks in Non-Small-Cell Lung Cancer

Thomas A Murray, Peter F Thall, P. Thall, 2017, Journal of the American Statistical Association.

Incidence and predictors of chest wall toxicity after high-dose radiation therapy in 15 fractions.

Joe Y. Chang, D. Gomez, J. Welsh, 2015, Practical radiation oncology.

Reirradiation of thoracic cancers with intensity modulated proton therapy.

Joe Y. Chang, Xiaodong Zhang, D. Gomez, 2018, Practical radiation oncology.

Early experience with intensity modulated proton therapy for lung-intact mesothelioma: A case series.

Xiaodong Zhang, D. Gomez, X. Zhu, 2015, Practical radiation oncology.

Phase II trial of concurrent atezolizumab with chemoradiation in unresectable non-small cell lung cancer.

Joe Y. Chang, P. Thall, D. Gomez, 2019, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

Stereotactic ablative radiotherapy (SABR) using 70 Gy in 10 fractions for non-small cell lung cancer: exploration of clinical indications.

Joe Y. Chang, D. Gomez, P. Balter, 2014, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Long‐Term Outcomes of Salvage Stereotactic Ablative Radiotherapy for Isolated Lung Recurrence of Non–Small Cell Lung Cancer: A Phase II Clinical Trial

Joe Y. Chang, D. Gomez, P. Balter, 2017, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

Correlation of osteoradionecrosis and dental events with dosimetric parameters in intensity-modulated radiation therapy for head-and-neck cancer.

J. Mechalakos, J. Shah, M. Zelefsky, 2011, International journal of radiation oncology, biology, physics.

Intensity-Modulated Radiotherapy After Extrapleural Pneumonectomy in the Combined-Modality Treatment of Malignant Pleural Mesothelioma

D. Gomez, R. Komaki, Z. Liao, 2011, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

An improved method for analyzing and reporting patterns of in-field recurrence after stereotactic ablative radiotherapy in early-stage non-small cell lung cancer.

Joe Y. Chang, C. Fuller, D. Gomez, 2020, Radiotherapy and Oncology.

Planning Target Volume D95 and Mean Dose Should Be Considered for Optimal Local Control for Stereotactic Ablative Radiation Therapy.

Joe Y. Chang, D. Gomez, Steven H. Lin, 2016, International journal of radiation oncology, biology, physics.

Response to Letter to Editor from Fodor et al., "The 'Radical' Palliation That Increases Survival in Malignant Pleural Mesothelioma".

D. Gomez, A. Rimner, 2019, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

Radiologic Considerations And Standardization Of Malignant Pleural Mesothelioma (MPM) Imaging Within Clinical Trials: Consensus Statement From The NCI Thoracic Malignancy Steering Committee - International Association For The Study Of Lung Cancer - Mesothelioma Applied Research Foundation Clinical T

S. Armato, E. Yorke, K. Rosenzweig, 2019, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

Patient-reported lung symptoms as an early signal of impending radiation pneumonitis in patients with non-small cell lung cancer treated with chemoradiation: an observational study

Tinsu Pan, Qiuling Shi, Charles S Cleeland, 2018, Quality of Life Research.

Single Nucleotide Polymorphisms in CBLB, a Regulator of T-Cell Response, Predict Radiation Pneumonitis and Outcomes After Definitive Radiotherapy for Non-Small-Cell Lung Cancer.

Hongliang Liu, Li-E. Wang, Q. Wei, 2016, Clinical lung cancer.

Esophageal cancer dose escalation using a simultaneous integrated boost technique.

J. Ajani, D. Gomez, S. Swisher, 2012, International journal of radiation oncology, biology, physics.

Radiation Time, Dose, and Fractionation in the Treatment of Lung Cancer

D. Gomez, R. Komaki, J. Cox, 2011 .

The Use of Radiation Therapy for the Treatment of Malignant Pleural Mesothelioma: Expert Opinion from the National Cancer Institute Thoracic Malignancy Steering Committee, International Association for the Study of Lung Cancer, and Mesothelioma Applied Research Foundation.

E. Yorke, K. Rosenzweig, V. Rusch, 2019, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

Hemithoracic intensity modulated radiation therapy after pleurectomy/decortication for malignant pleural mesothelioma: toxicity, patterns of failure, and a matched survival analysis.

Joe Y. Chang, D. Gomez, Z. Liao, 2015, International journal of radiation oncology, biology, physics.

Histopathologic characterization of radioactive iodine‐refractory fluorodeoxyglucose‐positron emission tomography‐positive thyroid carcinoma

S. Larson, D. Gomez, H. Schoder, 2008, Cancer.

Pulmonary resection is associated with long-term survival and should remain a therapeutic option in oligometastatic lung cancer.

D. Gomez, M. Antonoff, K. Mitchell, 2020, The Journal of thoracic and cardiovascular surgery.

Association of Long-term Outcomes and Survival With Multidisciplinary Salvage Treatment for Local and Regional Recurrence After Stereotactic Ablative Radiotherapy for Early-Stage Lung Cancer

Joe Y. Chang, K. Ahrar, D. Gomez, 2018, JAMA network open.

Influence of Surveillance PET/CT on Detection of Early Recurrence After Definitive Radiation in Stage III Non–small‐cell Lung Cancer

D. Gomez, J. Welsh, Z. Liao, 2017, Clinical lung cancer.

The impact of induction chemotherapy on the dosimetric parameters of subsequent radiotherapy: an investigation of 30 consecutive patients with locally-advanced non-small cell lung cancer and modern radiation planning techniques

D. Gomez, P. Allen, J. Grant, 2015, Radiation oncology.

Risk factors for local and regional recurrence in patients with resected N0-N1 non-small-cell lung cancer, with implications for patient selection for adjuvant radiation therapy.

D. Gomez, S. Swisher, R. Komaki, 2013, Annals of oncology : official journal of the European Society for Medical Oncology.

Prognostic Factors as a Function of Disease-free Interval After Definitive (Chemo)radiation for Non–Small Cell Lung Cancer Using Conditional Survival Analysis

D. Gomez, R. Komaki, Z. Liao, 2015, American journal of clinical oncology.

The Insurance Approval Process for Proton Radiation Therapy: A Significant Barrier to Patient Care.

Aashish K Shah, A. Garden, D. Gomez, 2019, International journal of radiation oncology, biology, physics.

Lung Cancer: Posttreatment Imaging Radiation Therapy and Imaging Findings

D. Gomez, E. Marom, B. Carter, 2017, Journal of thoracic imaging.

Recognizing Radiation Therapy-related Complications in the Chest.

D. Gomez, A. P. Benveniste, E. Marom, 2019, Radiographics : a review publication of the Radiological Society of North America, Inc.

Defining oligometastatic disease from a radiation oncology perspective: An ESTRO-ASTRO consensus document.

W. Woodward, Catherine C. Park, M. Scorsetti, 2020, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Adherence to national guidelines for antiemesis prophylaxis in patients undergoing chemotherapy for lung cancer

D. Gomez, Benjamin D. Smith, L. Elting, 2013, Cancer.

Prospective Exploratory Analysis of Cardiac Biomarkers and Electrocardiogram Abnormalities in Patients Receiving Thoracic Radiation Therapy with High-Dose Heart Exposure

Joe Y. Chang, D. Gomez, J. Welsh, 2014, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

Phase 2 Study of Stereotactic Body Radiation Therapy and Stereotactic Body Proton Therapy for High-Risk, Medically Inoperable, Early-Stage Non-Small Cell Lung Cancer.

Joe Y. Chang, R. Mohan, Xiaodong Zhang, 2018, International journal of radiation oncology, biology, physics.

Analysis of Factors Affecting Successful Clinical Trial Enrollment in the Context of Three Prospective, Randomized, Controlled Trials.

J. Lee, D. Gomez, J. Welsh, 2017, International journal of radiation oncology, biology, physics.

7‐year follow‐up after stereotactic ablative radiotherapy for patients with stage I non–small cell lung cancer: Results of a phase 2 clinical trial

Joe Y. Chang, J. Roth, D. Gomez, 2017, Cancer.

Postoperative Radiotherapy for Locally Advanced NSCLC: Implications for Shifting to Conformal, High-Risk Fields.

Joe Y. Chang, D. Gomez, Steven H. Lin, 2020, Clinical lung cancer.

Chapter 8 – Pleural Tumors

Joe Y. Chang, D. Gomez, M. Truong, 2012 .

The Role of Ablative Radiotherapy in Older Adults With Limited Metastatic Disease.

P. Iyengar, D. Gomez, D. Palma, 2022, Seminars in radiation oncology.

Improved survival outcomes with the incidental use of beta-blockers among patients with non-small-cell lung cancer treated with definitive radiation therapy.

D. Gomez, J. Welsh, R. Komaki, 2013, Annals of oncology : official journal of the European Society for Medical Oncology.

Radiation Oncologist Perceptions of Telemedicine from Consultation to Treatment Planning: A Mixed-Methods Study

D. Gomez, K. Lynch, E. Gillespie, 2020, International Journal of Radiation Oncology*Biology*Physics.

Cost Analysis of PET/CT Versus CT as Surveillance for Stage III Non–Small‐Cell Lung Cancer After Definitive Radiation Therapy

D. Gomez, J. Welsh, Z. Liao, 2018, Clinical lung cancer.

Need for Caution in the Diagnosis of Radiation Pneumonitis During the COVID-19 Pandemic

D. Gomez, A. Rimner, A. Wu, 2020, Advances in Radiation Oncology.

Long-term outcomes of phase I/II prospective study of dose-escalated proton therapy for early-stage non-small cell lung cancer

Joe Y. Chang, R. Mohan, Xiaodong Zhang, 2017 .

Scientific Advances in Lung Cancer 2015

Kenneth E. Rosenzweig, Hisao Asamura, Annette McWilliams, 2016, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

Long-Term Survival Outcomes of Cancer-Directed Surgery for Malignant Pleural Mesothelioma: Propensity Score Matching Analysis.

J. Roth, D. Gomez, S. Swisher, 2017, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Low rate of thoracic toxicity in palliative paraspinal single-fraction stereotactic body radiation therapy.

K. Rosenzweig, Y. Yamada, M. Zelefsky, 2009, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Staging and prognosis

D. Gomez, R. Komaki, G. Walsh, 2013 .

Development of the International Thymic Malignancy Interest Group International Database: An Unprecedented Resource for the Study of a Rare Group of Tumors

A. Nicholson, W. Travis, A. Catlin, 2014, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

Biochemical response to androgen deprivation therapy before external beam radiation therapy predicts long-term prostate cancer survival outcomes.

M. Zelefsky, D. Gomez, X. Pei, 2013, International journal of radiation oncology, biology, physics.

Stereotactic ablative radiation therapy for pulmonary metastases: Improving overall survival and identifying subgroups at high risk of local failure.

D. Gomez, J. Welsh, P. Balter, 2020, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Time to treatment as a quality metric in lung cancer: Staging studies, time to treatment, and patient survival.

D. Gomez, S. Swisher, T. Buchholz, 2015, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Genetic variants of the nonhomologous end joining gene LIG4 and severe radiation pneumonitis in nonsmall cell lung cancer patients treated with definitive radiotherapy

Q. Wei, D. Gomez, R. Komaki, 2012, Cancer.

Re-evaluating the Optimal Radiation Dose for Definitive Chemoradiotherapy for Esophageal Squamous Cell Carcinoma

Joe Y. Chang, D. Gomez, Steven H. Lin, 2014, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

Patterns of Local-Regional Failure After Intensity Modulated Radiation Therapy or Passive Scattering Proton Therapy With Concurrent Chemotherapy for Non-Small Cell Lung Cancer.

R. Mohan, D. Gomez, Z. Liao, 2019, International journal of radiation oncology, biology, physics.

Polymorphisms in BMP2/BMP4, with estimates of mean lung dose, predict radiation pneumonitis among patients receiving definitive radiotherapy for non-small cell lung cancer

D. Gomez, Z. Liao, S. Hahn, 2017, Oncotarget.

Lymphopenia association with gross tumor volume and lung V5 and its effects on non-small cell lung cancer patient outcomes.

D. Gomez, J. Welsh, R. Komaki, 2014, International journal of radiation oncology, biology, physics.

Factors Associated With Age Disparities Among Cancer Clinical Trial Participants.

Charles R. Thomas, R. Jagsi, C. Fuller, 2019, JAMA oncology.

Sex-Based Disparities Among Cancer Clinical Trial Participants.

E. Holliday, R. Jagsi, C. Fuller, 2019, Journal of the National Cancer Institute.

Thoracic radiation oncology clinical trial accrual and reasons for non-enrollment: results of a large, prospective, multi-year analysis.

Joe Y. Chang, D. Gomez, Steven H. Lin, 2020, International journal of radiation oncology, biology, physics.

Patterns of Failure, Toxicity, and Survival after Extrapleural Pneumonectomy and Hemithoracic Intensity-Modulated Radiation Therapy for Malignant Pleural Mesothelioma

D. Gomez, R. Komaki, Z. Liao, 2013, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

Proton therapy for early-stage non-small cell lung cancer (NSCLC).

Joe Y. Chang, D. Gomez, Heng Li, 2018, Translational lung cancer research.

Accelerated dose escalation with proton beam therapy for non-small cell lung cancer.

Joe Y. Chang, D. Gomez, 2014, Journal of thoracic disease.

Stereotactic ablative radiotherapy for adrenal gland metastases: Factors influencing outcomes, patterns of failure, and dosimetric thresholds for toxicity.

Joe Y. Chang, D. Gomez, J. Welsh, 2017, Practical radiation oncology.

Impact of Corticosteroid Administration on Outcomes Following Stereotactic Ablative Radiotherapy for Non-small-cell Lung Cancer.

Joe Y. Chang, D. Gomez, J. Welsh, 2019, Clinical lung cancer.

Proton Therapy in Non-small Cell Lung Cancer

D. Gomez, S. Mesko, 2018, Current Treatment Options in Oncology.

EBUS-TBNA in the nodal staging of Stereotactic ablative body radiotherapy patients

Joe Y. Chang, K. A. Khan, D. Gomez, 2017 .

Cardiac ¹⁸F-fluorodeoxyglucose uptake on positron emission tomography after thoracic stereotactic body radiation therapy.

Joe Y. Chang, G. Gladish, D. Gomez, 2013, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

TU-D-207B-02: Delta-Radiomics: The Prognostic Value of Therapy-Induced Changes in Radiomics Features for Stage III Non-Small Cell Lung Cancer Patients.

D. Mackin, X. Fave, L. Court, 2016, Medical physics.

Predictors of trimodality therapy and trends in therapy for malignant pleural mesothelioma†

J. Roth, D. Gomez, S. Swisher, 2018, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

Do angiotensin-converting enzyme inhibitors reduce the risk of symptomatic radiation pneumonitis in patients with non-small cell lung cancer after definitive radiation therapy? Analysis of a single-institution database.

D. Gomez, Z. Liao, L. Levy, 2013, International journal of radiation oncology, biology, physics.

Metastatic Disease as a Distinct Discipline in Radiation Oncology.

D. Gomez, T. Yang, C. Tsai, 2020, JAMA oncology.

Delivering safe and effective stereotactic body radiation therapy for patients with centrally located early stage non-small cell lung cancer.

D. Gomez, A. Rimner, A. Wu, 2020, Chinese clinical oncology.

A Randomized Phase II Trial of Adjuvant Galinpepimut-S, WT-1 Analogue Peptide Vaccine, After Multimodality Therapy for Patients with Malignant Pleural Mesothelioma

M. Zauderer, V. Rusch, D. Scheinberg, 2017, Clinical Cancer Research.

Local and Systemic Therapies for Malignant Pleural Mesothelioma

D. Gomez, A. Tsao, 2014, Current Treatment Options in Oncology.

Radiotherapy-Induced Malfunction in Contemporary Cardiovascular Implantable Electronic Devices: Clinical Incidence and Predictors.

D. Gomez, S. Kry, S. Krishnan, 2015, JAMA oncology.

Special topics in immunotherapy and radiation therapy: reirradiation and palliation.

D. Gomez, T. Evans, C. Ciunci, 2007, Translational lung cancer research.

Phase II Trial of Ipilimumab with Stereotactic Radiation Therapy for Metastatic Disease: Outcomes, Toxicities, and Low-Dose Radiation–Related Abscopal Responses

Joe Y. Chang, K. Hess, D. Gomez, 2019, Cancer Immunology Research.

Deﬁning oligometastatic disease from a radiation oncology perspective: An ESTRO-ASTRO consensus document Radiotherapy and Oncology

W. Woodward, M. Scorsetti, P. Iyengar, 2020 .

Radiotherapy After Surgical Resection for Head and Neck Mucosal Melanoma

J. Shah, M. Zelefsky, J. Wolchok, 2009, American journal of clinical oncology.

Association between white blood cell count following radiation therapy with radiation pneumonitis in non-small cell lung cancer.

D. Gomez, R. Komaki, Z. Liao, 2014, International journal of radiation oncology, biology, physics.

Polymorphisms of Homologous Recombination Genes and Clinical Outcomes of Non-Small Cell Lung Cancer Patients Treated with Definitive Radiotherapy

Q. Wei, D. Gomez, Z. Liao, 2011, PloS one.

Lymphocyte Nadir and Esophageal Cancer Survival Outcomes After Chemoradiation Therapy.

D. Gomez, J. Welsh, Steven H. Lin, 2017, International journal of radiation oncology, biology, physics.

Early and Midtreatment Mortality in Palliative Radiotherapy: Emphasizing Patient Selection in High-Quality End-of-Life Care.

Joe Y. Chang, D. Gomez, A. Koong, 2021, Journal of the National Comprehensive Cancer Network : JNCCN.

Postoperative Radiation Therapy Is Associated with Longer Overall Survival in Completely Resected Stage II and III Thymoma—An Analysis of the International Thymic Malignancies Interest Group Retrospective Database

D. Gomez, F. Detterbeck, A. Rimner, 2016, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

Emerging Paradigm of Consolidative Thoracic Radiotherapy in Oligometastatic NSCLC.

D. Gomez, T. Yang, C. Tsai, 2021, Seminars in radiation oncology.

Radiation pneumonitis in lung cancer patients treated with chemoradiation plus durvalumab

E. Yorke, J. Deasy, D. Gomez, 2020, Cancer medicine.

Radiotherapy for Thymic Carcinoma: Adjuvant, Inductive, and Definitive

D. Gomez, R. Komaki, 2014, Front. Oncol..

Outcomes and toxicity following high-dose radiation therapy in 15 fractions for non-small cell lung cancer.

D. Gomez, Steven H. Lin, Z. Liao, 2017, Practical radiation oncology.

Association Between the Early Discontinuation of Durvalumab and Poor Survival in Patients With Stage III NSCLC

D. Gomez, M. Hellmann, J. Chaft, 2021, JTO clinical and research reports.

Utilization and factors precluding the initiation of consolidative durvalumab in unresectable stage III non-small cell lung cancer.

C. Rudin, D. Gomez, M. Hellmann, 2019, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Treatment Modalities and Outcomes in Patients With Advanced Invasive Thymoma or Thymic Carcinoma: A Retrospective Multicenter Study

K. Rosenzweig, D. Gomez, R. Komaki, 2016, American journal of clinical oncology.

Technical advances of radiation therapy for thymic malignancies.

D. Gomez, R. Komaki, 2010, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

Low rate of thoracic toxicity in palliative paraspinal single-fraction stereotactic body radiation therapy.

K. Rosenzweig, Y. Yamada, M. Zelefsky, 2009, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Malfunctions of implantable cardiac devices in patients receiving proton beam therapy: incidence and predictors.

Joe Y. Chang, R. Mohan, D. Gomez, 2013, International journal of radiation oncology, biology, physics.

Clinical and Dosimetric Factors Predicting Grade ≥2 Radiation Pneumonitis After Postoperative Radiotherapy for Patients With Non-Small Cell Lung Carcinoma.

R. Mohan, D. Gomez, R. Komaki, 2018, International journal of radiation oncology, biology, physics.

Radiation Followed by OX40 Stimulation Drives Local and Abscopal Antitumor Effects in an Anti–PD1-Resistant Lung Tumor Model

Joe Y. Chang, D. Gomez, J. Welsh, 2018, Clinical Cancer Research.

Clinical and pathologic prognostic features in acinic cell carcinoma of the parotid gland

J. Shah, M. Zelefsky, D. Gomez, 2009, Cancer.

Outcomes and prognostic variables in adenoid cystic carcinoma of the head and neck: a recent experience.

J. Shah, D. Gomez, D. Kraus, 2008, International journal of radiation oncology, biology, physics.

Differences in Normal Tissue Response in the Esophagus Between Proton and Photon Radiation Therapy for Non-Small Cell Lung Cancer Using In Vivo Imaging Biomarkers.

R. Mohan, M. Martel, Jinzhong Yang, 2017, International journal of radiation oncology, biology, physics.

Simultaneous Integrated Boost for Radiation Dose Escalation to the Gross Tumor Volume With Intensity Modulated (Photon) Radiation Therapy or Intensity Modulated Proton Therapy and Concurrent Chemotherapy for Stage II to III Non-Small Cell Lung Cancer: A Phase 1 Study.

R. Mohan, Xiaodong Zhang, D. Gomez, 2017, International journal of radiation oncology, biology, physics.

Locally Advanced Non-Small Cell Lung Cancer and Small Cell Lung Cancer

D. Gomez, P. Balter, Z. Liao, 2014 .

Safety of Thoracic Radiotherapy in Patients with Prior Immune-Related Adverse Events from Immune Checkpoint Inhibitors.

D. Gomez, M. Hellmann, J. Chaft, 2020, Annals of oncology : official journal of the European Society for Medical Oncology.

Intensity modulated radiotherapy for stage III non-small cell lung cancer in the United States: predictors of use and association with toxicities.

Joe Y. Chang, S. Shirvani, Jing Jiang, 2013, Lung cancer.

A prospective phase 2 study of surgery followed by chemotherapy and radiation for superior sulcus tumors

J. Roth, D. Gomez, S. Swisher, 2012, Cancer.

Propensity score-matched analysis of comprehensive local therapy for oligometastatic non-small cell lung cancer that did not progress after front-line chemotherapy.

D. Gomez, S. Swisher, G. Rao, 2014, International journal of radiation oncology, biology, physics.

Prognostic impact of radiation therapy to the primary tumor in patients with non-small cell lung cancer and oligometastasis at diagnosis.

D. Gomez, S. Swisher, Steven H. Lin, 2012, International journal of radiation oncology, biology, physics.

Suppression of Type I IFN Signaling in Tumors Mediates Resistance to Anti-PD-1 Treatment That Can Be Overcome by Radiotherapy.

Joe Y. Chang, D. Gomez, J. Welsh, 2017, Cancer research.

An individual patient data metaanalysis of outcomes and prognostic factors after treatment of oligometastatic non-small-cell lung cancer.

Umberto Ricardi, Suresh Senan, Giulio Melloni, 2014, Clinical lung cancer.

In Reply to Sert.

D. Gomez, S. Mesko, 2021, International journal of radiation oncology, biology, physics.

Phase II Study of Hemithoracic Intensity-Modulated Pleural Radiation Therapy (IMPRINT) As Part of Lung-Sparing Multimodality Therapy in Patients With Malignant Pleural Mesothelioma.

E. Yorke, K. Rosenzweig, M. Zauderer, 2016, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Proton Beam Radiotherapy and Concurrent Chemotherapy for Unresectable Stage III Non–Small Cell Lung Cancer: Final Results of a Phase 2 Study

Joe Y. Chang, R. Mohan, Xiaodong Zhang, 2017, JAMA oncology.

Poster PresentationThe 5-Year Outcome for Patients Diagnosed With Locally Advanced Non-Small Cell Lung Cancer Treated With Definitive Concurrent Chemotherapy and Proton Beam Therapy: Locally Advanced Non-Small Cell Lung Cancer

D. Gomez, R. Komaki, Z. Liao, 2014 .

Feasibility of proton beam therapy for reirradiation of locoregionally recurrent non-small cell lung cancer.

Joe Y. Chang, D. Gomez, R. Komaki, 2013, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Consolidative Use of Radiotherapy to Block (CURB) Oligoprogression ― Interim Analysis of the First Randomized Study of Stereotactic Body Radiotherapy in Patients With Oligoprogressive Metastatic Cancers of the Lung and Breast

C. Rudin, D. Gomez, S. Powell, 2021, International Journal of Radiation Oncology*Biology*Physics.

Increased Biologically Effective Dose (BED) To the Primary Tumor is Associated with Improved Survival in Patients with Oligometastatic NSCLC.

Joe Y. Chang, D. Gomez, M. Antonoff, 2021, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

What Is the Optimal SABA Dose for Local Control After Stereotactic Ablative Radiation Therapy in Lung Cancer: A 10 Year Experience of 1092 Patients

D. Gomez, P. Balter, J. Welsh, 2015 .

Clinical Outcome and Toxicity in Central Located Stage I or Isolated Recurrent Non-Small Cell Lung Cancer Treated With Stereotactic Ablative Radiation Therapy

J. Roth, D. Gomez, S. Swisher, 2013 .

Use of simultaneous radiation boost achieves high control rates in patients with non-small-cell lung cancer who are not candidates for surgery or conventional chemoradiation.

Joe Y. Chang, D. Gomez, J. Welsh, 2015, Clinical lung cancer.

Phase 1 study of dose escalation in hypofractionated proton beam therapy for non-small cell lung cancer.

Joe Y. Chang, D. Gomez, Steven H. Lin, 2013, International journal of radiation oncology, biology, physics.

Assessing the robustness of passive scattering proton therapy with regard to local recurrence in stage III non-small cell lung cancer: a secondary analysis of a phase II trial

Joe Y. Chang, W. Liu, R. Mohan, 2014, Radiation oncology.

Return to intended oncologic treatment after surgery for malignant pleural mesothelioma.

D. Gomez, A. Tsao, R. Mehran, 2019, The Journal of thoracic and cardiovascular surgery.

Defining the role of adjuvant radiotherapy for malignant pleural mesothelioma: a propensity-matched landmark analysis of the National Cancer Database.

J. Roth, D. Gomez, S. Swisher, 2019, Journal of thoracic disease.

Serum inflammatory miRNAs predict radiation esophagitis in patients receiving definitive radiochemotherapy for non-small cell lung cancer.

Q. Wei, D. Gomez, J. Welsh, 2014, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

ATM polymorphisms predict severe radiation pneumonitis in patients with non-small cell lung cancer treated with definitive radiation therapy.

Hongliang Liu, Q. Wei, D. Gomez, 2013, International journal of radiation oncology, biology, physics.

Functional polymorphisms of base excision repair genes XRCC1 and APEX1 predict risk of radiation pneumonitis in patients with non-small cell lung cancer treated with definitive radiation therapy.

Daniel Gomez, Zhongxing Liao, Li-E Wang, 2011, International journal of radiation oncology, biology, physics.

Genomic Analyses for Predictors of Response to Chemoradiation in Stage III Non-Small Cell Lung Cancer

D. Gomez, P. Paik, R. Samstein, 2020, Advances in radiation oncology.

Prognostic factors of recurrence in salivary carcinoma ex pleomorphic adenoma, with emphasis on the carcinoma histologic subtype: a clinicopathologic study of 43 cases.

D. Gomez, N. Lee, N. Katabi, 2010, Human pathology.

Current and Future Management of Malignant Mesothelioma: A Consensus Report from the National Cancer Institute Thoracic Malignancy Steering Committee, International Association for the Study of Lung Cancer, and Mesothelioma Applied Research Foundation

K. Rosenzweig, M. Zauderer, V. Rusch, 2018, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

Pathologic considerations and standardization in mesothelioma clinical trials.

A. Nicholson, F. Galateau-Sallé, D. Gomez, 2019, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

Strategies for combining immunotherapy with radiation for anticancer therapy.

Joe Y. Chang, D. Gomez, J. Welsh, 2015, Immunotherapy.

The Impact of Durvalumab on Local Regional Control in Stage III Non-Small Cell Lung Cancers Treated with Chemoradiation and on KEAP1/NFE2L2 Mutant Tumors.

D. Gomez, P. Paik, M. Hellmann, 2021, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

PDL1 Regulation by p53 via miR-34

G. Calin, K. Kelnar, D. Gomez, 2015, Journal of the National Cancer Institute.

Bayesian Adaptive Randomization Trial of Passive Scattering Proton Therapy and Intensity-Modulated Photon Radiotherapy for Locally Advanced Non-Small-Cell Lung Cancer.

Radhe Mohan, Stephen M Hahn, John V Heymach, 2018, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Neoadjuvant Chemotherapy Increases Cytotoxic T cell, Tissue Resident Memory T cell and B Cell Infiltration in Resectable Non-Small Cell Lung Cancer.

Jing Wang, I. Wistuba, D. Gomez, 2020, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

Impact of Telemedicine on Patient Satisfaction and Perceptions of Care Quality in Radiation Oncology.

D. Gomez, C. Washington, T. Atkinson, 2021, Journal of the National Comprehensive Cancer Network : JNCCN.

Integrative proteomic and transcriptomic analysis provides evidence for TrkB (NTRK2) as a therapeutic target in combination with tyrosine kinase inhibitors for non-small cell lung cancer

Jing Wang, W. Hong, I. Wistuba, 2018, Oncotarget.

Radiation Therapy Definitions and Reporting Guidelines for Thymic Malignancies

D. Gomez, A. Bezjak, R. Komaki, 2011, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

Management of Synchronous Extrathoracic Oligometastatic Non-Small Cell Lung Cancer

David R. Jones, V. Rusch, M. Bains, 2021, Cancers.

Translational Research and Immunotherapy in Lung Cancer

D. Gomez, J. Welsh, Z. Liao, 2016 .

Clinical and Dosimetric Predictors of Radiation Pneumonitis in Patients with Non-Small Cell Lung Cancer Undergoing Post-Operative Radiation Therapy.

E. Yorke, D. Gomez, J. Chaft, 2020, Practical radiation oncology.

Intensity-modulated radiotherapy in postoperative treatment of oral cavity cancers.

J. Shah, D. Gomez, D. Kraus, 2009, International journal of radiation oncology, biology, physics.

Safety of hemithoracic pleural intensity-modulated radiation therapy (IMRT) for malignant pleural mesothelioma (MPM) in the multimodality setting: Interim analysis of a phase II study

E. Yorke, K. Rosenzweig, M. Zauderer, 2013 .

Results of a Phase 1/2 Trial of Chemoradiotherapy With Simultaneous Integrated Boost of Radiotherapy Dose in Unresectable Locally Advanced Esophageal Cancer.

Joe Y. Chang, K. Hess, J. Ajani, 2019, JAMA oncology.

Local Consolidative Therapy Vs. Maintenance Therapy or Observation for Patients With Oligometastatic Non-Small-Cell Lung Cancer: Long-Term Results of a Multi-Institutional, Phase II, Randomized Study.

J. Lee, D. Gomez, J. Welsh, 2019, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Intensity-modulated proton therapy further reduces normal tissue exposure during definitive therapy for locally advanced distal esophageal tumors: a dosimetric study.

Daniel Gomez, Lei Dong, Zhongxing Liao, 2011, International journal of radiation oncology, biology, physics.

D. Gomez, R. Howell, C. Pinnix, 2015, Future oncology.

Potentially Functional Variants of ATG16L2 Predict Radiation Pneumonitis and Outcomes in Patients with Non–Small Cell Lung Cancer after Definitive Radiotherapy

Hongliang Liu, Q. Wei, D. Gomez, 2018, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

Combinations of Radiation Therapy and Chemotherapy for Non-Small Cell and Small-Cell Lung Carcinoma

D. Gomez, R. Komaki, Z. Liao, 2014 .

Local Consolidative Therapy versus Maintenance Therapy/Observation for Patients with Oligometastatic Non-Small Cell Lung Cancer without Progression after Front-Line Systemic Therapy: Results of a Multi-Institutional Phase II Randomized Study

J. Lee, D. Gomez, S. Swisher, 2016, The Lancet. Oncology.

Phase I Trial of Definitive Concurrent Chemoradiotherapy and Trametinib for KRAS-Mutated Non-Small Cell Lung Cancer.

P. Thall, D. Gomez, Steven H. Lin, 2022, Cancer treatment and research communications.

Definition of Oligometastatic Disease from a Radiation Oncology perspective : 1 an ESTRO-ASTRO Consensus Document 2 3

W. Woodward, Catherine C. Park, M. Scorsetti, 2019 .

Local Ablative Therapies in Oligometastatic NSCLC: New Data and New Directions

D. Gomez, D. Palma, P. Lang, 2020, Seminars in Respiratory and Critical Care Medicine.

When Should we Irradiate the Primary in Metastatic Lung Cancer?

D. Gomez, F. McDonald, A. Shiarli, 2019, Clinical oncology (Royal College of Radiologists (Great Britain)).

Oligometastatic Disease at Presentation or Recurrence for Nonsmall Cell Lung Cancer

Joe Y. Chang, D. Gomez, Y. Niibe, 2012, Pulmonary medicine.

Optimizing adjuvant therapy in EGFR-mutated non-small cell lung cancer

D. Gomez, A. Rimner, A. Wu, 2020, Annals of translational medicine.

Metastasis-directed therapy for oligometastasis and beyond

D. Gomez, C. Tsai, T. Beckham, 2020, British journal of cancer.

Clinical Outcomes of Dose-Escalated Hypofractionated External Beam Radiation Therapy (5 Gy × 5 Fractions) for Spine Metastasis

Y. Yamada, D. Gomez, D. Higginson, 2022, Advances in radiation oncology.

An International Expert Survey on the Indications and Practice of Radical Thoracic Reirradiation for Non-Small Cell Lung Cancer

D. Gomez, D. de Ruysscher, A. Louie, 2021, Advances in radiation oncology.

Stereotactic ablative radiation therapy for centrally located early stage or isolated parenchymal recurrences of non-small cell lung cancer: how to fly in a "no fly zone".

Joe Y. Chang, J. Roth, D. Gomez, 2014, International journal of radiation oncology, biology, physics.

Biologically Effective Dose in Stereotactic Body Radiotherapy and Survival for Patients with Early-Stage Non-Small Cell Lung Cancer.

Joe Y. Chang, D. Gomez, Steven H. Lin, 2019, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

Failure Patterns Relative to Radiation Treatment Fields for Stage II–IV Thymoma

E. Yorke, K. Rosenzweig, D. Gomez, 2014, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

Treatment planning and outcomes effects of reducing the preferred mean esophagus dose for conventionally fractionated non‐small cell lung cancer radiotherapy

E. Yorke, D. Gomez, A. Jackson, 2021, Journal of applied clinical medical physics.

Development and application of an elastic net logistic regression model to investigate the impact of cardiac substructure dose on radiation-induced pericardial effusion in patients with NSCLC

Jinzhong Yang, L. Court, D. Gomez, 2020, Acta oncologica.

Challenges in Re-Irradiation in the Thorax: Managing Patients with Locally Recurrent Non-Small Cell Lung Cancer.

D. Gomez, J. Bradley, C. Robinson, 2020, Seminars in radiation oncology.

Clinical outcomes, local-regional control and the role for metastasis-directed therapies in stage III non-small cell lung cancers treated with chemoradiation and durvalumab.

C. Rudin, M. Kris, D. Gomez, 2020, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Automatic segmentation of cardiac substructures from noncontrast CT images: accurate enough for dosimetric analysis?

Daniel Gomez, Zhongxing Liao, Laurence E Court, 2018, Acta oncologica.

Trends and Outcomes of Proton Radiation Therapy Use for Non–Small Cell Lung Cancer

Joe Y. Chang, D. Gomez, Steven H. Lin, 2018, International journal of particle therapy.

Radiation Dose, Local Disease Progression, and Overall Survival in Patients With Inoperable Non-Small Cell Lung Cancer After Concurrent Chemoradiation Therapy.

D. Gomez, Y. Liu, R. Komaki, 2018, International journal of radiation oncology, biology, physics.

Incidence and Predictors of Pericardial Effusion After Chemoradiation Therapy for Locally Advanced Non-Small Cell Lung Cancer.

D. Gomez, Z. Liao, J. Huo, 2017, International journal of radiation oncology, biology, physics.

Cardiac atlas development and validation for automatic segmentation of cardiac substructures.

Tinsu Pan, Zhongxing Liao, Jinzhong Yang, 2017, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Long-term outcomes after proton therapy, with concurrent chemotherapy, for stage II-III inoperable non-small cell lung cancer.

Joe Y. Chang, D. Gomez, R. Komaki, 2015, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Increasing Heart Dose Reduces Overall Survival in Patients Undergoing Postoperative Radiation Therapy for NSCLC

E. Yorke, D. Gomez, J. Chaft, 2021, JTO clinical and research reports.

Comparative Outcomes After Definitive Chemoradiotherapy Using Proton Beam Therapy Versus Intensity Modulated Radiation Therapy for Esophageal Cancer: A Retrospective, Single-Institutional Analysis.

Joe Y. Chang, J. Ajani, D. Gomez, 2017, International journal of radiation oncology, biology, physics.

Combining Radiation and Immunotherapy: A New Systemic Therapy for Solid Tumors?

D. Gomez, J. Welsh, P. Sharma, 2014, Cancer Immunology Research.

Evaluating single-institution resource costs of consolidative radiotherapy for oligometastatic non-small cell lung cancer using time-driven activity-based costing

D. Gomez, O. Gjyshi, Chad Tang, 2019, Clinical and translational radiation oncology.

Stereotactic ablative body radiation for oligometastatic and oligoprogressive disease.

D. Gomez, S. Swisher, M. Ning, 2018, Translational lung cancer research.

Systemic and oligo-acquired resistance to PD-(L)1 blockade in lung cancer.

C. Rudin, V. Rusch, R. Perez-Johnston, 2022, Clinical Cancer Research.

Unresectable carcinoma of the paranasal sinuses: outcomes and toxicities.

J. Shah, M. Zelefsky, D. Gomez, 2008, International journal of radiation oncology, biology, physics.

Stereotactic Ablative Radiation Therapy Combined With Immunotherapy for Solid Tumors.

Joe Y. Chang, D. Gomez, J. Welsh, 2016, Cancer journal.

An investigation of intensity-modulated radiation therapy versus conventional two-dimensional and 3D-conformal radiation therapy for early stage larynx cancer

J. Mechalakos, D. Gomez, N. Lee, 2010, Radiation oncology.

Genomic analysis and clinical correlations of non-small cell lung cancer (NSCLC) brain metastasis (BM).

N. Schultz, K. Yu, D. Gomez, 2022, Journal of Clinical Oncology.

Combining radiation plus immunotherapy to improve systemic immune response.

Joe Y. Chang, D. Gomez, J. Welsh, 2018, Journal of thoracic disease.

Cancer Immunology at the Crossroads: Complementary Therapeutic Modalities Combining Radiation and Immunotherapy: A New Systemic Therapy for Solid Tumors?

D. Gomez, J. Welsh, P. Sharma, 2014 .

Applying Artificial Intelligence to Address the Knowledge Gaps in Cancer Care.

Daniel Gomez, Lynda Chin, Koichi Takahashi, 2018, The oncologist.

TNFRSF1B +676 T>G polymorphism predicts survival of non-Small cell lung cancer patients treated with chemoradiotherapy

Q. Wei, D. Gomez, R. Komaki, 2011, BMC Cancer.

Changes in Pulmonary Function after Three-Dimensional Conformal Radiation Therapy, Intensity-Modulated Radiation Therapy, or Proton Beam Therapy for Non-Small Cell Lung Cancer

R. Mohan, D. Gomez, Z. Liao, 2014 .

Changes in pulmonary function after three-dimensional conformal radiotherapy, intensity-modulated radiotherapy, or proton beam therapy for non-small-cell lung cancer.

R. Mohan, D. Gomez, R. Komaki, 2012, International journal of radiation oncology, biology, physics.

Radiation Effects in the Mediastinum and Surroundings: Imaging Findings and Complications.

D. Gomez, E. Marom, B. Carter, 2016, Seminars in ultrasound, CT, and MR.

Incidental receipt of cardiac medications and survival outcomes among patients with stage III non-small-cell lung cancer after definitive radiotherapy.

D. Gomez, Y. Liu, Z. Liao, 2015, Clinical lung cancer.

Palliative Radiation Therapy for Oncologic Emergencies in the Setting of COVID-19: Approaches to Balancing Risks and Benefits

D. Gomez, K. Beal, E. Gillespie, 2020, Advances in Radiation Oncology.

Novel Inpatient Radiation Oncology Consult Service Model Reduces Hospital Length of Stay.

D. Gomez, S. Powell, O. Cahlon, 2021, JCO oncology practice.

Rapid Access Multidisciplinary Bone Metastases Clinic Decreases Financial Toxicity for Patients Undergoing Palliative Radiation

D. Gomez, A. Koong, V. Lewis, 2019, International Journal of Radiation Oncology*Biology*Physics.

Influence of Age on Guideline-Concordant Cancer Care for Elderly Patients in the United States.

R. Jagsi, D. Gomez, Benjamin D. Smith, 2017, International journal of radiation oncology, biology, physics.

Current Practice Influence of Age on Guideline-Concordant Cancer Care for Elderly Patients in the United States

R. Jagsi, D. Gomez, Benjamin D. Smith, 2017 .

Aortic dose constraints when reirradiating thoracic tumors.

M. Martel, D. Gomez, J. Welsh, 2013, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Clinical utility of next-generation sequencing-based ctDNA testing for common and novel ALK fusions.

David R. Jones, M. Berger, C. Rudin, 2021, Lung cancer.

Radiation Therapy is Independently Associated With Worse Survival After R0 Resection for Stage I-II Non-Small Cell Lung cancer: An Analysis of the National Cancer Data Base.

D. Gomez, S. Hahn, P. Blanchard, 2017, International journal of radiation oncology, biology, physics.

Postoperative Radiation Therapy for Non-Small Cell Lung Cancer and Thymic Malignancies

D. Gomez, R. Komaki, 2012, Cancers.

Endobronchial Ultrasound-Guided Transbronchial Needle Aspiration in the Nodal Staging of Stereotactic Ablative Body Radiotherapy Patients.

Joe Y. Chang, D. Gomez, H. Grosu, 2017, The Annals of thoracic surgery.

Racial disparities in guideline-concordant cancer care and mortality in the United States

R. Jagsi, D. Gomez, Benjamin D. Smith, 2018, Advances in radiation oncology.

Thoracic Radiation Therapy During Coronavirus Disease 2019: Provisional Guidelines from a Comprehensive Cancer Center within a Pandemic Epicenter

E. Yorke, D. Gomez, A. Rimner, 2020, Advances in Radiation Oncology.

HSPB1 gene polymorphisms predict risk of mortality for US patients after radio(chemo)therapy for non-small cell lung cancer.

R. Mohan, Q. Wei, D. Gomez, 2012, International journal of radiation oncology, biology, physics.

Functional promoter rs2868371 variant of HSPB1 associates with radiation-induced esophageal toxicity in patients with non-small-cell lung cancer treated with radio(chemo)therapy.

Q. Wei, D. Gomez, Z. Liao, 2011, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Quantitative assessment of target delineation variability for thymic cancers: agreement evaluation of a prospective segmentation challenge

Jayashree Kalpathy-Cramer, Clifton D. Fuller, Daniel Gomez, 2016, Journal of Radiation Oncology.

Nomograms incorporating genetic variants in BMP/Smad4/Hamp pathway to predict disease outcomes after definitive radiotherapy for non‐small cell lung cancer

D. Gomez, R. Komaki, Z. Liao, 2018, Cancer medicine.

Impact of image preprocessing on the volume dependence and prognostic potential of radiomics features in non-small cell lung cancer

Peter A Balter, Jinzhong Yang, Lifei Zhang, 2016 .

Large Decreases in Standardized Uptake Values After Definitive Radiation Are Associated with Better Survival of Patients with Locally Advanced Non–Small Cell Lung Cancer

G. Gladish, D. Gomez, R. Komaki, 2012, The Journal of Nuclear Medicine.

Surgical Complexity of Pulmonary Resections Performed for Oligometastatic NSCLC

D. Gomez, S. Swisher, R. Mehran, 2022, JTO clinical and research reports.

Local Consolidation Therapy (LCT) After First Line Tyrosine Kinase Inhibitor (TKI) for Patients With EGFR Mutant Metastatic Non–small‐cell Lung Cancer (NSCLC)

J. Roth, D. Gomez, S. Swisher, 2019, Clinical lung cancer.

Stereotactic Ablative Radiation Therapy is Highly Safe and Effective for Elderly Patients With Early-stage Non-Small Cell Lung Cancer.

Joe Y. Chang, D. Gomez, J. Welsh, 2017, International Journal of Radiation Oncology, Biology, Physics.

Survival and Patterns of Failure in Oligometastatic Esophagogastric Cancer

S. Sihag, D. Gomez, Y. Janjigian, 2020, International Journal of Radiation Oncology, Biology, Physics.

Update: Modern Approaches to the Treatment of Localized Esophageal Cancer

J. Ajani, D. Gomez, R. Komaki, 2011, Current oncology reports.

Objectively Quantifying Radiation Esophagitis With Novel Computed Tomography-Based Metrics.

R. Mohan, M. Martel, Jinzhong Yang, 2016, International journal of radiation oncology, biology, physics.

Clinical implementation of intensity modulated proton therapy for thoracic malignancies.

Heng Li, Joe Y. Chang, Zhongxing Liao, 2014, International journal of radiation oncology, biology, physics.

[Radiation therapy definitions and reporting guidelines for thymic malignancies].

Daniel Gomez, Andrea Bezjak, D. Gomez, 2014, Zhongguo fei ai za zhi = Chinese journal of lung cancer.

Definitive reirradiation for locoregionally recurrent non-small cell lung cancer with proton beam therapy or intensity modulated radiation therapy: predictors of high-grade toxicity and survival outcomes.

Joe Y. Chang, D. Gomez, R. Komaki, 2014, International journal of radiation oncology, biology, physics.

A Novel Methodology using CT Imaging Biomarkers to Quantify Radiation Sensitivity in the Esophagus with Application to Clinical Trials

R. Mohan, M. Martel, Jinzhong Yang, 2017, Scientific Reports.

(18)F-Fluorodeoxyglucose Positron Emission Tomography Can Quantify and Predict Esophageal Injury During Radiation Therapy.

R. Mohan, M. Martel, Jinzhong Yang, 2016, International journal of radiation oncology, biology, physics.

DNA repair capacity correlates with standardized uptake values from 18F-fluorodeoxyglucose positron emission tomography/CT in patients with advanced non–small-cell lung cancer

Q. Wei, L. Court, D. Gomez, 2018, Chronic diseases and translational medicine.

Long-term outcome of phase I/II prospective study of dose-escalated proton therapy for early-stage non-small cell lung cancer.

Radhe Mohan, Joe Y. Chang, Daniel Gomez, 2017, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Change in diffusing capacity after radiation as an objective measure for grading radiation pneumonitis in patients treated for non-small-cell lung cancer.

R. Mohan, D. Gomez, R. Komaki, 2012, International journal of radiation oncology, biology, physics.

Definitive Local Consolidative Therapy for Oligometastatic Solid Tumors: Results from the Lead-In Phase of the Randomized Basket Trial EXTEND.

T. Bathala, D. Gomez, P. Corn, 2022, International journal of radiation oncology, biology, physics.

Stereotactic ablative radiotherapy: A potentially curable approach to early stage multiple primary lung cancer

Joe Y. Chang, J. Roth, D. Gomez, 2013, Cancer.

Reduced Incidence of Severe Acute Toxicities in Esophageal Cancer Treated with Proton Therapy

D. Gomez, Steven H. Lin, R. Komaki, 2015 .

Local Consolidative Therapy (LCT) Improves Overall Survival (OS) Compared to Maintenance Therapy/Observation in Oligometastatic Non-Small Cell Lung Cancer (NSCLC): Final Results of a Multicenter, Randomized, Controlled Phase 2 Trial

J. Lee, D. Gomez, S. Swisher, 2018, International Journal of Radiation Oncology, Biology, Physics.

Local Treatment of 'Oligometastases': Wishful Thinking is Not Supported by Available Evidence - Authors' Reply.

D. Gomez, D. Palma, F. McDonald, 2020, Clinical oncology (Royal College of Radiologists (Great Britain)).

Prospective Study of Patient-Reported Symptom Burden in Patients With Non-Small-Cell Lung Cancer Undergoing Proton or Photon Chemoradiation Therapy.

Joe Y. Chang, R. Mohan, D. Gomez, 2016, Journal of pain and symptom management.

Minimal residual disease (MRD) detection by ctDNA in relation to radiographic disease progression in patients with stage I-III non–small cell lung cancer (NSCLC) treated with definitive radiation therapy.

David R. Jones, C. Rudin, M. Kris, 2022, Journal of Clinical Oncology.

Consolidative local therapy in oligometastatic patients - Authors' reply.

D. Gomez, S. Swisher, J. Heymach, 2017, The Lancet. Oncology.

Postoperative Hemithoracic Intensity Modulated Radiation Therapy (IMRT) With an Optional Integrated Boost for Malignant Pleural Mesothelioma: Toxicity, Patterns of Failure, and a Matched Survival Analysis

D. Gomez, Z. Liao, J. Welsh, 2014 .

Incidental Use of Beta-Blockers, Serum VEGF, and Their Association With Disease Outcome in Patients with Non-Small-Cell Lung Cancer Treated with Definitive Chemoradiation Therapy.

D. Gomez, Z. Liao, J. Huo, 2017, International Journal of Radiation Oncology, Biology, Physics.

Effects of Chemotherapy Regimen and Radiation Modality on Hematologic Toxicities in Patients Receiving Definitive Platinum-based Doublet Chemoradiation for Non–Small Cell Lung Cancer

D. Gomez, R. Komaki, Z. Liao, 2017, American journal of clinical oncology.

Prognosis and predictors of site of first metastasis after definitive radiation therapy for non-small cell lung cancer

K. Hess, D. Gomez, R. Komaki, 2016, Acta oncologica.

Proton energy optimization and reduction for intensity-modulated proton therapy

Li Liao, Daniel Gomez, Shengpeng Jiang, 2014, Physics in medicine and biology.

Association of lung fluorodeoxyglucose uptake with radiation pneumonitis after concurrent chemoradiation for non-small cell lung cancer

T. Pan, D. Gomez, R. Komaki, 2017, Clinical and translational radiation oncology.

Reirradiation of Thoracic Cancers with Intensity Modulated Proton Therapy.

D. Gomez, X. Zhu, R. Komaki, 2017, International journal of radiation oncology, biology, physics.

Imaging of Radiation Treatment of Lung Cancer.

D. Gomez, A. P. Benveniste, E. Marom, 2018, Seminars in ultrasound, CT, and MR.

Bayesian randomized trial comparing intensity modulated radiation therapy versus passively scattered proton therapy for locally advanced non-small cell lung cancer.

Radhe Mohan, Daniel Gomez, James D. Cox, 2016 .

Predictors of high-grade esophagitis after definitive three-dimensional conformal therapy, intensity-modulated radiation therapy, or proton beam therapy for non-small cell lung cancer.

R. Mohan, M. Martel, D. Gomez, 2012, International journal of radiation oncology, biology, physics.

Prognostic Value of Positron Emission Tomography/Computed Tomography Findings in Limited-stage Small Cell Lung Cancer Before Chemoradiation Therapy

G. Gladish, D. Gomez, R. Komaki, 2014, American journal of clinical oncology.

High Flow Nasal Cannula Therapy for Exertional Dyspnea in Cancer Patients: A Pilot Randomized Clinical Trial.

E. Bruera, K. Hess, D. Gomez, 2020, The oncologist.

Prospective Phase 1/2 Clinical Trial: Evaluating Dose-Escalation for Esophageal Cancer

J. Ajani, D. Gomez, S. Swisher, 2015 .

An individual patient data metaanalysis of outcomes and prognostic factors after treatment of oligometastatic non-small-cell lung cancer.

D. Gomez, G. Melloni, S. Senan, 2014, Clinical lung cancer.

Stereotactic ablative radiation therapy for centrally located early stage or isolated parenchymal recurrences of non-small cell lung cancer: how to fly in a "no fly zone".

Joe Y. Chang, J. Roth, D. Gomez, 2014, International journal of radiation oncology, biology, physics.

Comparison of 2 common radiation therapy techniques for definitive treatment of small cell lung cancer.

Joe Y. Chang, S. Shirvani, D. Gomez, 2013, International journal of radiation oncology, biology, physics.

Acute phase response before treatment predicts radiation esophagitis in non-small cell lung cancer.

M. Martel, D. Gomez, R. Komaki, 2014, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Association of prior radiation dose to the cardiopulmonary system with COVID-19 outcomes in patients with cancer

D. Gomez, M. Thor, Q. LaPlant, 2021, Radiotherapy and Oncology.

MSK-ACCESS for noninvasive somatic mutation profiling of lung cancers utilizing circulating tumor DNA.

David R. Jones, M. Ladanyi, M. Berger, 2020 .

Phase 2 5-Arm Trial of Ipilimumab Plus Lung or Liver Stereotactic Radiation for Patients with Advanced Malignancies

D. Gomez, J. Welsh, R. Komaki, 2017 .

The Pulmonary Fibrosis Associated MUC5B Promoter Polymorphism Is Prognostic of the Overall Survival in Patients with Non–Small Cell Lung Cancer (NSCLC) Receiving Definitive Radiotherapy

D. Gomez, Z. Liao, L. Levy, 2017, Translational oncology.

Suppression of Type I IFN Signaling in Tumors Mediates Resistance to Anti-PD-1 Treatment That Can Be Overcome by Radiotherapy.

Joe Y. Chang, D. Gomez, J. Welsh, 2017, Cancer research.

Clinical and Radiographic Presentations of COVID-19 Among Patients Receiving Radiation Therapy for Thoracic Malignancies

Joe Y. Chang, D. Gomez, Steven H. Lin, 2020, Advances in Radiation Oncology.

Predictors of high-grade esophagitis after definitive three-dimensional conformal therapy, intensity-modulated radiation therapy, or proton beam therapy for non-small cell lung cancer.

R. Mohan, M. Martel, D. Gomez, 2012, International journal of radiation oncology, biology, physics.

A technique to use CT images for in vivo detection and quantification of the spatial distribution of radiation‐induced esophagitis

Laurence E. Court, Daniel Gomez, Lei Dong, 2013, Journal of applied clinical medical physics.

Single Nucleotide Polymorphisms in CBLB, a Regulator of T-Cell Response, Predict Radiation Pneumonitis and Outcomes After Definitive Radiotherapy for Non-Small-Cell Lung Cancer.

Hongliang Liu, D. Gomez, J. Welsh, 2016, Clinical lung cancer.

Oral Abstract PresentationAn Individual Patient Data Meta-Analysis of Outcomes and Prognostic Factors After Treatment of Oligometastatic Non-Small Cell Lung Cancer: Metastatic Non-Small Cell Lung Cancer

D. Gomez, G. Melloni, S. Senan, 2014 .

Functional promoter rs189037 variant of ATM is associated with decrease in lung diffusing capacity after irradiation for non–small-cell lung cancer

D. Gomez, Z. Liao, Q. Nguyen, 2018, Chronic diseases and translational medicine.